Being a heterogeneous tumor, BrCa is divided into four various molecular subtypes according to genetic profiles, including Basal-like, Luminal-A, Luminal-B, and human epidermal growth factor 2 (HER2)-positive BrCa (Yeo and Guan, 2017). Here, ERBB2 is linked to invasive breast carcinoma.